Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like SKF Motion Technologies introduces CASM-100 electromechanical actuators September 6, 2018 New Electric Actuator Pushes up to 40 Short Tons at 13 Inches per Second February 21, 2018 USFDA issues warning letter to Indoco Remedies’ Goa plant April 12, 2017